7-92235531-G-C
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_194454.3(KRIT1):c.601C>G(p.Gln201Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_194454.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRIT1 | ENST00000394505.7 | c.601C>G | p.Gln201Glu | missense_variant | Exon 8 of 19 | 1 | NM_194454.3 | ENSP00000378013.2 | ||
ENSG00000289027 | ENST00000692281.1 | c.601C>G | p.Gln201Glu | missense_variant | Exon 8 of 26 | ENSP00000510568.1 | ||||
ENSG00000285953 | ENST00000458493.6 | c.601C>G | p.Gln201Glu | missense_variant | Exon 7 of 20 | 4 | ENSP00000396352.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cerebral cavernous malformation 1 Pathogenic:1
- -
not provided Pathogenic:1
The Q201E variant has been published previously in association with familial cerebral cavernous malformation (CCM) (Verlaan et al., 2002; Battistini et al., 2007; Haghighi et al., 2013). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Q201E is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Several in-silico splice prediction models predict that c.601 C>G creates a cryptic donor site which supplants the natural donor site and leads to abnormal gene splicing. Additionally, RNA studies have shown the variant causes a portion of exon 9 (referred to as exon 8 in the publication) to be lost, resulting in a frameshift variant (Verlaan et al., 2002). In summary, we consider this variant to be pathogenic. -
Cerebral cavernous malformation Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KRIT1 protein function. ClinVar contains an entry for this variant (Variation ID: 5726). This missense change has been observed in individual(s) with cerebral cavernous malformations (PMID: 24007869). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 201 of the KRIT1 protein (p.Gln201Glu). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at